A shortage of IV fluid in the wake of Hurricane Helene is shining a spotlight on the fragility and vulnerability of the ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

The Therapeutic Goods Administration has given Pfizer's new COVID-19 jab the green light. But what about vaccines from ...

Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment ...

The FDA approved the company's COVID vaccine in October 2023. The stock has gained 111% in the year to date, while the S&P 500 SPX has gained 22%. This content was created by MarketWatch, which is ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter. The ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

Canada will not be providing Novavax for the 2024/25 season, leaving those who would have preferred an alternative to the ...

COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased ...

Among the mothers, Auger's group found that HS was associated with a threefold higher risk of infection (HR 3.37, 95% CI 2.86-3.99) and a fourfold higher risk of allergy hospitalizations (RR 4.02, 95% ...